selected publications
- Assessing routes of hepatitis C transmission in HIV-infected men who have sex with men using single genome sequencing. PloS one. 2020 Academic Article GET IT
-
Ledipasvir/Sofosbuvir for 8 Weeks to Treat Acute Hepatitis C Virus Infections in Men With Human Immunodeficiency Virus Infections: Sofosbuvir-Containing Regimens Without Interferon for Treatment of Acute HCV in HIV-1 Infected Individuals.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
2019
Academic Article
GET IT
Times cited: 4 -
Management of Hepatitis C in 2019.
JAMA.
2019
Article
GET IT
Times cited: 8 -
Benefit of Early versus Deferred Antiretroviral Therapy on Progression of Liver Fibrosis among People with HIV in the START Randomized Trial.
Hepatology (Baltimore, Md.).
2019
Academic Article
GET IT
Times cited: 2 -
Management of hepatitis B and C infections in rheumatologic disease.
Best practice & research. Clinical rheumatology.
2018
Review
GET IT
Times cited: 1 -
Effects of sofosbuvir-based hepatitis C treatment on the pharmacokinetics of tenofovir in HIV/HCV-coinfected individuals receiving tenofovir disoproxil fumarate.
The Journal of antimicrobial chemotherapy.
2018
Academic Article
GET IT
Times cited: 5 -
Hepatitis C Management Simplification From Test to Cure: A Framework for Primary Care Providers.
Clinical therapeutics.
2018
Academic Article
GET IT
Times cited: 11 -
Hepatitis C Treatment Outcomes for People Who Inject Drugs Treated in an Accessible Care Program Located at a Syringe Service Program.
Open forum infectious diseases.
2018
Academic Article
GET IT
Times cited: 15 -
The albumin-bilirubin grade uncovers the prognostic relationship between hepatic reserve and immune dysfunction in HIV-associated hepatocellular carcinoma.
Alimentary pharmacology & therapeutics.
2017
Academic Article
GET IT
Times cited: 7 -
Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for prevention.
PloS one.
2017
Academic Article
GET IT
Times cited: 23 -
Sofosbuvir Plus Ribavirin Without Interferon for Treatment of Acute Hepatitis C Virus Infection in HIV-1-Infected Individuals: SWIFT-C.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
2017
Academic Article
GET IT
Times cited: 23 -
Phase 3 trial of first generation protease inhibitor therapy for hepatitis C virus/human immunodeficiency virus coinfection.
World journal of hepatology.
2017
Academic Article
GET IT
Times cited: 2 -
Do directly acting antiviral agents for HCV increase the risk of hepatic decompensation and decline in renal function? Results from ERCHIVES.
Alimentary pharmacology & therapeutics.
2016
Academic Article
GET IT
Times cited: 27 - Herpes Simplex Virus Hepatitis in an Immunocompetent Host Resembling Hepatic Pyogenic Abscesses. Case reports in hepatology. 2016 Academic Article GET IT
-
Adding ribavirin to newer DAA regimens does not affect SVR rates in HCV genotype 1 infected persons: results from ERCHIVES.
Alimentary pharmacology & therapeutics.
2016
Academic Article
GET IT
Times cited: 10 -
The Risk of Cardiovascular Disease, Diabetes, Liver-Related Outcomes, and Death Over 10 Years in HIV/HCV-Coinfected Patients With and Without Steatosis.
AIDS research and human retroviruses.
2016
Academic Article
GET IT
Times cited: 6 -
Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus.
Hepatology (Baltimore, Md.).
2015
Academic Article
GET IT
Times cited: 852 -
Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1.
The New England journal of medicine.
2015
Academic Article
GET IT
Times cited: 326 -
Addition of nitazoxanide to PEG-IFN and ribavirin to improve HCV treatment response in HIV-1 and HCV genotype 1 coinfected persons naïve to HCV therapy: results of the ACTG A5269 trial.
HIV clinical trials.
2013
Academic Article
GET IT
Times cited: 4 -
Depression and fatigue in chronic hepatitis C patients with and without HIV co-infection.
Psychosomatics.
2013
Academic Article
GET IT
Times cited: 11 -
Rapid progression to decompensated cirrhosis, liver transplant, and death in HIV-infected men after primary hepatitis C virus infection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
2012
Academic Article
GET IT
Times cited: 42 -
The first wave: HCV NS3 protease inhibitors telaprevir and boceprevir.
Antiviral therapy.
2012
Review
GET IT
Times cited: 26 -
Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset.
Blood.
2011
Academic Article
GET IT
Times cited: 125 -
Risk factors for thrombocytopenia in HIV-infected persons in the era of potent antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999).
2009
Academic Article
GET IT
Times cited: 33 -
Autoimmune hepatitis in the HIV-infected patient: a therapeutic dilemma.
AIDS patient care and STDs.
2009
Academic Article
GET IT
Times cited: 16 -
Understanding the pathogenesis and management of hepatitis B/HIV and hepatitis B/hepatitis C virus coinfection.
Clinics in liver disease.
2007
Review
GET IT
Times cited: 13 -
Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study.
Journal of hepatology.
2007
Academic Article
GET IT
Times cited: 176 - New Antiretroviral Agents for the Treatment of HIV Infection. Current infectious disease reports. 2004 Academic Article GET IT
-
New antiretroviral agents for the treatment of HIV infection.
Current HIV/AIDS reports.
2004
Review
GET IT
Times cited: 6